Atria Investments’s Invesco BulletShares 2031 Corporate Bond ETF BSCV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
66,402
-102,932
-61% -$1.69M 0.01% 1068
2026
Q1
$2.79M Sell
169,334
-6,221
-4% -$104K 0.03% 555
2025
Q4
$2.93M Buy
175,555
+16,322
+10% +$273K 0.03% 572
2025
Q3
$2.66M Sell
159,233
-128,940
-45% -$2.14M 0.03% 608
2025
Q2
$4.76M Sell
288,173
-90,994
-24% -$1.48M 0.06% 397
2025
Q1
$6.18M Buy
379,167
+76,663
+25% +$1.24M 0.08% 304
2024
Q4
$4.86M Buy
302,504
+25,556
+9% +$416K 0.06% 356
2024
Q3
$4.62M Buy
276,948
+28,667
+12% +$471K 0.06% 378
2024
Q2
$3.96M Buy
248,281
+16,510
+7% +$263K 0.05% 412
2024
Q1
$3.74M Buy
+231,771
New +$3.74M 0.05% 422

Other funds holding BSCV

Atria Investments's BSCV Position: Q2 2026 in Review

Atria Investments reduced its Invesco BulletShares 2031 Corporate Bond ETF (BSCV) stake by 61% in Q2 2026, selling an estimated $1.69M and leaving 66,402 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #1068.

Atria Investments first reported a position in BSCV in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.18M in Q1 2025. 221 funds tracked by Wall St. Rank hold BSCV as of Q2 2026.

  • Atria Investments held 66,402 shares of Invesco BulletShares 2031 Corporate Bond ETF worth $1.09M as of Q2 2026.
  • Atria Investments sold 102,932 Invesco BulletShares 2031 Corporate Bond ETF shares in Q2 2026, an estimated $1.69M.
  • Invesco BulletShares 2031 Corporate Bond ETF made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1068 holding.
  • Atria Investments first reported a position in Invesco BulletShares 2031 Corporate Bond ETF in Q1 2024 and has held it in 10 quarters since.
  • Atria Investments's Invesco BulletShares 2031 Corporate Bond ETF position peaked at $6.18M in Q1 2025.
  • 221 funds tracked by Wall St. Rank held Invesco BulletShares 2031 Corporate Bond ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.